首页> 外文期刊>The Egyptian Journal of Hospital Medicine >The effect of Sitagliptin (Januvia) on the liver of adult Albino rats in cases of experimental diabetes mellitus(Microscopic and laboratory studies)
【24h】

The effect of Sitagliptin (Januvia) on the liver of adult Albino rats in cases of experimental diabetes mellitus(Microscopic and laboratory studies)

机译:西他列汀(Januvia)对实验性糖尿病患者成年白化病大鼠肝脏的影响(显微和实验室研究)

获取原文
           

摘要

Introduction: The present study was carried out to evaluate the effect of Sitagliptin (Januvia) on the liver of experimentally induced diabetes in albino rats. Material and Methods: Fifteen adult male albino rats were used and divided into three equal groups. The first group was considered as a control group. In the second group experimental induction of diabetes was performed by intraperitoneal injection of alloxan and left as a diabetic control for three weeks. The third group was consisted of rats of experimentally induced diabetes and treated by a daily dose of Sitagliptin (Januvia) as oral anti diabetic therapy for three weeks. Two main parameters were performed; the first was microscopic and histochemical studies on the liver tissue while the second was laboratory evaluation of some liver functions. Results: The hepatic tissue was affected by the experimental induction of diabetes in the form of cellular infiltration, hepatic cell cords disarrangement and vascular congestion after three weeks of induction. The fibrous elements as well as mucopolysaccharides contents were greatly reduced. Histochemical changes in the liver enzymes showed mild decrease. Liver function tests showed mild changes. Diabetic changes were gradually returned back to its normal state after the use of daily oral dose of Sitagliptin. Conclusions: The antidiabetic drug (Sitagliptin) could be considered a good therapy in limiting the risk of diabetes Mellitus on liver tissue
机译:简介:本研究旨在评估西他列汀(Januvia)对白化病大鼠实验性糖尿病肝脏的影响。材料与方法:使用十五只成年雄性白化病大鼠,将其分成三等分。第一组被认为是对照组。在第二组中,通过腹膜内注射四氧嘧啶进行实验性糖尿病诱导,并作为糖尿病对照放置三周。第三组由实验诱发的糖尿病大鼠组成,并通过每日剂量的西他列汀(Januvia)作为口服抗糖尿病药物治疗三周。执行了两个主要参数;第一个是对肝脏组织的显微和组织化学研究,第二个是对某些肝功能的实验室评估。结果:诱导后三周,实验性诱导的糖尿病以肝细胞浸润,肝细胞帘线紊乱和血管充血的形式影响了肝组织。纤维元素以及粘多糖的含量大大降低。肝酶的组织化学变化显示轻度下降。肝功能检查显示轻度变化。每日口服西他列汀后,糖尿病患者的病情逐渐恢复至正常状态。结论:抗糖尿病药(西他列汀)可被认为是限制糖尿病对肝组织风险的一种有效疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号